IBM Watson Health will use the power of cognitive computing to help Pfizer with the development of cancer drugs.
The Armonk, N.Y.-based computer giant’s supercomputer Watson will help Pfizer speed up research and development of drugs that use the body’s immune system to fight cancer. Pfizer claims to be one of the first companies to use Watson’s abilities for drug discovery and the first to use it for immuno-oncology—lucrative types of drugs that could be a major revenue source for Pfizer if its research succeeds.
